Winter Park, Florida--(Newsfile Corp. - January 20, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and personalized healthcare, today announced that it has been notified by the U.S. Securities and Exchange Commission (SEC) that its Form 10 registration statement will not be subject to further review. As a result, the Form 10 will automatically become effective 60 days after its original filing date, which is February 3, 2026.The Form 10, originally filed on December 5, 2025, r ...

Winter Park, Florida--(Newsfile Corp. - January 15, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), through its medical division Adia Med specializing in advanced regenerative therapies, announces that Emmanuela Derisbrun, APRN, FNP-C, has transitioned from subcontractor to employed provider. This move supports rising patient volume and the launch of Adia Med's IRB-approved autism spectrum disorder regenerative study.Emmanuela Derisbrun, APRN, FNP-CTo view an enhanced version of this graphic, please visit:https ...

Winter Park, Florida--(Newsfile Corp. - January 13, 2026) - ADIA Nutrition Inc. (OTCQB: ADIA), today announced that its subsidiary, Adia Med of Winter Park, LLC., has officially begun the recruitment process for a groundbreaking clinical study evaluating the potential benefits of stem cell therapy in children with Autism Spectrum Disorder (ASD). The 24-month randomized interventional study, officially titled "Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study" and listed on ClinicalTrials. ...

Winter Park, Florida--(Newsfile Corp. - January 5, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine through its subsidiary Adia Med, today announced that its patent-pending clinical study targeting Autism Spectrum Disorder (ASD) has gone live on ClinicalTrials.gov, marking a significant advancement in the company's research pipeline.Clinical trial NCT07304440To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/279460_adi ...

Winter Park, Florida--(Newsfile Corp. - December 29, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions, today announced a year-end recap of its pivotal 2025 achievements. The company delivered remarkable financial performance, operational expansion, and strategic milestones, positioning itself for sustained growth and an anticipated Nasdaq uplisting."2025 has been a defining year of execution and momentum for Adia Nutrition," s ...

Core Insights - Adia Labs has formed a strategic marketing partnership with BoldMD to enhance the expansion of Axia MD's chiropractor-hosted pop-up longevity clinics across the United States [1][2] Group 1: Partnership and Expansion - The collaboration with BoldMD builds on Adia Labs' existing partnership with Axia MD, which provides physician oversight in all 50 states, creating a compliant platform for scalable growth [2] - The pop-up clinics leverage a network of over 70,000 licensed chiropractors in the U.S., with the chiropractic profession expected to grow approximately 10% over the next decade, more than double the average growth rate for all occupations [3] Group 2: Marketing and Patient Acquisition - BoldMD will implement targeted patient acquisition campaigns, brand development, AI-powered CRM tools, and data-driven marketing strategies to enhance patient retention and optimize marketing efficiency [5] - The partnership aims to support rapid scaling as new clinic locations are launched nationwide, providing advanced regenerative therapies under full physician oversight [3][5] Group 3: Company Overview and Services - Adia Nutrition Inc. specializes in stem cell and regenerative products, with its lab division, Adia Labs LLC, expanding to include insurance-billable wound care products [7] - Revenue is generated through service fees, product sales, equity stakes, and billing insurance for healthcare treatments, with a focus on innovative healthcare solutions [8]

Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med subsidiary, today announced that the independent Institutional Review Board (IRB) BeyondBound has approved the company's patent-pending clinical study protocol focused on Autism Spectrum Disorder (ASD).IRB Approval EmailTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/278050_adia_irb_approved_screenshot.jp ...

Core Insights - Adia Nutrition Inc. has filed a Form 10 registration statement with the SEC, marking a strategic step towards achieving full reporting status [1][2][4] - The filing aims to enhance transparency, improve corporate governance, and strengthen the company's regulatory standing in public markets [2][4] - Once effective, the Form 10 will require Adia to provide regular disclosures, including audited financials, under the Securities Exchange Act of 1934 [3] Company Overview - Adia Nutrition Inc. is based in Winter Park, Florida, and focuses on advancing healthcare through innovative stem cell and regenerative products [8] - The company operates through its lab division, Adia Labs LLC, and is expanding its offerings to include insurance-billable wound care products [8] - Adia Med clinics provide specialized regenerative treatments, including stem cell therapies and advanced wound repair services [8][9] Revenue Generation - Revenue is generated through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [9] - The company also invests in aligned businesses, such as Cement Factory LLC, which focuses on health and wellness [9]

Core Insights - Adia Nutrition Inc. has partnered with Dr. Asa Andrew, a prominent health talk show host, to promote its stem cell therapies and enhance public awareness of regenerative medicine [2][5][6] Company Overview - Adia Nutrition Inc. is a publicly traded company based in Winter Park, Florida, specializing in stem cell and regenerative products, including AdiaVita and AdiaLink [6] - The company operates Adia Med clinics that focus on orthopedic, pain management, and wound repair, offering advanced treatments such as stem cell therapies and platelet-rich plasma (PRP) [6][7] Partnership Details - Dr. Asa Andrew will serve as the official media partner for Adia Med, creating exclusive content across various platforms to educate the public about stem cell therapy and its benefits [4][5] - The partnership aims to increase awareness, education, and access to life-changing treatments in the field of regenerative medicine [5][6] Business Model - Revenue for Adia Nutrition Inc. is generated through service fees, product sales, equity stakes, and insurance billing for healthcare treatments [7] - The company is expanding its offerings to include insurance-billable wound care products through its lab division, Adia Labs LLC [6][7]

ADIA Nutrition Inc. to Host Webinar on HSCT for MS and Autoimmune Conditions with HSCT WarriorsNovember 19, 2025 9:30 AM EST | Source: Adia Nutrition Inc.Winter Park, Florida--(Newsfile Corp. - November 19, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) invites all shareholders, supporters, and potential investors to join a live webinar tomorrow, Thursday, November 20, 2025, at 6:30 PM EST, hosted by HSCT Warriors.HSCT WarriorsTo view an enhanced version of this graphic, please visit:https://image ...